Pediatrix Medical Group (NYSE:MD) Stock Rating Lowered by Wall Street Zen

Key Points

• Wall Street Zen downgraded Pediatrix Medical Group from “strong buy” to “buy,” while the broader analyst consensus remains “hold” with an average price target of $26.60.
• Pediatrix reported quarterly EPS of $0.63, beating estimates of $0.59, while revenue reached $487.78 million and increased 4.1% year over year.
• The stock opened at $27.03, near its 52-week high of $27.94, and institutional investors own approximately 97.71% of the company’s shares.

Pediatrix Medical Group (NYSE:MD - Get Free Report) was downgraded by stock analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating in a note issued to investors on Saturday, Wall Street Zen reports.

Other equities analysts have also issued research reports about the stock. Deutsche Bank Aktiengesellschaft restated a "hold" rating and set a $25.00 price target on shares of Pediatrix Medical Group in a research report on Wednesday, August 5th. Weiss Ratings lowered shares of Pediatrix Medical Group from a "buy (b-)" rating to a "hold (c+)" rating in a research note on Tuesday, August 25th. Truist Financial upped their target price on shares of Pediatrix Medical Group from $23.00 to $28.00 and gave the stock a "hold" rating in a research report on Tuesday, July 14th. Mizuho set a $24.00 price target on shares of Pediatrix Medical Group in a research note on Friday, May 8th. Finally, UBS Group lifted their price target on Pediatrix Medical Group from $25.00 to $28.00 and gave the company a "neutral" rating in a report on Thursday, August 6th. Six equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat, Pediatrix Medical Group currently has a consensus rating of "Hold" and an average target price of $26.60.

Pediatrix Medical Group Stock Up 0.6%

NYSE:MD opened at $27.03 on Friday. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.45. The stock has a 50 day moving average of $26.32 and a 200-day moving average of $23.37. The firm has a market capitalization of $2.20 billion, a PE ratio of 12.93 and a beta of 0.64. Pediatrix Medical Group has a 52 week low of $15.69 and a 52 week high of $27.94.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last released its quarterly earnings data on Tuesday, August 4th. The company reported $0.63 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.59 by $0.04. The business had revenue of $487.78 million during the quarter, compared to analyst estimates of $478.49 million. Pediatrix Medical Group had a return on equity of 20.05% and a net margin of 8.96%.The business's revenue for the quarter was up 4.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.53 EPS. Analysts predict that Pediatrix Medical Group will post 2.17 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of MD. Burney Co. acquired a new stake in shares of Pediatrix Medical Group during the first quarter worth $1,129,000. Fifth Third Bancorp increased its stake in Pediatrix Medical Group by 7,643.2% in the 1st quarter. Fifth Third Bancorp now owns 62,333 shares of the company's stock worth $1,333,000 after purchasing an additional 61,528 shares in the last quarter. Renaissance Technologies LLC raised its holdings in Pediatrix Medical Group by 12.9% during the 1st quarter. Renaissance Technologies LLC now owns 1,532,300 shares of the company's stock worth $32,776,000 after buying an additional 174,600 shares during the period. Ritholtz Wealth Management lifted its stake in Pediatrix Medical Group by 42.1% during the first quarter. Ritholtz Wealth Management now owns 143,668 shares of the company's stock valued at $3,073,000 after buying an additional 42,553 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC boosted its holdings in shares of Pediatrix Medical Group by 52.5% in the first quarter. Allspring Global Investments Holdings LLC now owns 975,133 shares of the company's stock worth $20,185,000 after buying an additional 335,733 shares during the period. 97.71% of the stock is owned by institutional investors and hedge funds.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc NYSE: MD is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source